The Digital Tracking Pill is Here – 2057 Came Early
As featured theoretical physicist Michio Kaku suggested in the release of 2057: The World in 50 Years (a popular Netflix USA documentary, released back in 2007), the first drug-digital tracking pill hybrid for the U.S. market has arrived.
It was approved by the Food and Drug Administration (FDA) on Monday. The regulation clearance sets a precedence, as revolutionary changes in both the medical and high-tech fields continue to evolve.
According to the FDA, there hasn’t been an established association between using the digital pill platform and increased patient adherence to their drug regimens.
More on the pill: The Abilify MyCite pill (developed by Otsuka Pharmaceutical Co Ltd), currently used to treat a wide range of mental disorders is modified to include a data relay sensor. Upon consumption, the sensor sends messages to a patch; which patients are instructed to wear on their torso area. From there, the patch sends messages to the associative smartphone application (citing details about the intake). Completing the information transaction (with permission from their patients), doctors and health care members can access the drug tracking data via an online portal.
The development of the sensor and patch for the Abilify pill was completed by Proteus Digital Health–but there are other developers working on this as well. Namely, Intarcia and Braeburn Pharmaceuticals, which are currently working to develop digital tracking implants, designed to disperse treatment at 6 month intervals, potentially benefiting those with chronic conditions.
Changes in how drugs are delivered into the body opens an opportunity for one to take back some of the estimated billions in wasted medical spending due to patients not taking their medications. So, will we all be denied future medical care because we skipped a pill as the story was unfolded in the 2057: The World in 50 Years documentary?
To that end, one can only guess. Nonetheless, with this advance, all should be more informed about their medication consumption habits.